Health · Seattle ·
Lila Bio receives $3.65 million NIH grant for research
Seattle startup Lila Bio received a $3.65 million NIH grant to develop an AI-designed protein treatment for pulmonary hypertension. The research is in lab and animal-testing stages.
1 report
Headline and summary written by the Acta Diurna desk using only what the outlets above reported. Read their reporting for the full story. How we stay neutral.
Seattle news today · More Health · Seattle prediction markets